- Report
- June 2024
- 200 Pages
Global
From €7601EUR$7,950USD£6,363GBP
- Report
- April 2024
- 270 Pages
Global
From €4780EUR$5,000USD£4,002GBP
- Report
- July 2023
- 200 Pages
Global
From €4446EUR$4,650USD£3,722GBP
- Report
- July 2023
- 150 Pages
Global
From €5689EUR$5,950USD£4,762GBP
- Report
- October 2023
- 190 Pages
Global
From €4302EUR$4,500USD£3,601GBP
- Report
- July 2023
- 115 Pages
Global
From €4302EUR$4,500USD£3,601GBP
RNA Therapy Clinical Trials are a form of gene therapy that uses RNA molecules to treat diseases. RNA molecules are used to deliver genetic material to cells, which can then be used to modify the expression of a gene or to replace a mutated gene. This type of therapy has been used to treat a variety of diseases, including cancer, cardiovascular disease, and neurological disorders.
RNA Therapy Clinical Trials involve the use of a variety of technologies, such as gene editing, gene silencing, and gene delivery. These technologies are used to modify the expression of a gene or to replace a mutated gene. The goal of these trials is to determine the safety and efficacy of the therapy.
Companies involved in the RNA Therapy Clinical Trials market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Moderna Therapeutics. These companies are focused on developing therapies that use RNA molecules to treat a variety of diseases. Show Less Read more